English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, April 22, 2020
Fujitsu Receives Supercomputer Order from JAXA, Further Enhancing Global Competitiveness in Aerospace Research
Tuesday, April 21, 2020
富士通、健康経営への取り組みを支援するクラウド型健康管理支援システム「LifeMark HealthAssist」を提供開始
Friday, April 17, 2020
Fujitsu Develops Easy to Handle, Flexible Nanotube Adhesive Sheet Technology with High Thermal Conductivity
富士通研究所、裁断やハンドリングが可能な高熱伝導カーボンナノチューブ接着シートを開発
Wednesday, April 15, 2020
Fujitsu Verifies AI Technology to Predict Vessel Collision Risks in Marine Traffic Control, Improves Maritime Safety
Monday, May 22, 2023
Tokyo Tech, Tohoku University, Fujitsu, and RIKEN start collaboration to develop distributed training of Large Language Models
Thursday, May 18, 2023
Fujitsu launches Biodrug Design Accelerator platform to accelerate peptide drug discovery research
富士通、ペプチド創薬の研究プロセスを管理するプラットフォーム「Biodrug Design Accelerator」を提供開始
Wednesday, May 17, 2023
京都大学・Chordia Therapeutics・富士通、因果関係を発見するAI技術を用いてがんの新薬に対するバイオマーカーを発見する実証実験を開始
Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs
Fujitsu Ltd Links

https://plus.google.com/+Fujitsu

https://www.facebook.com/FujitsuJapan

https://twitter.com/Fujitsu_Global

https://www.youtube.com/user/FujitsuOfficial

https://www.linkedin.com/company/fujitsu/

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575